Suppr超能文献

小剂量促肾上腺皮质激素试验显示,吸入糖皮质激素的患者肾上腺功能受损。

Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids.

作者信息

Broide J, Soferman R, Kivity S, Golander A, Dickstein G, Spirer Z, Weisman Y

机构信息

Department of Pediatrics, Dana Children's Hospital Faculty of Medicine, Tel Aviv University, Israel.

出版信息

J Clin Endocrinol Metab. 1995 Apr;80(4):1243-6. doi: 10.1210/jcem.80.4.7714095.

Abstract

The aim of the present study was to examine the use of low-dose ACTH-(1-24) stimulation for assessment of adrenal function and the detection of mild adrenal insufficiency. The criteria for normal response to ACTH-(1-24) are a peak cortisol level of more than 500 nmol/L (18.1 micrograms/dL) and an increment of the cortisol level above the basal one of more than 200 nmol/L (7.2 micrograms/dL). These criteria were satisfied by 32 of 33 healthy children and adults subjected to an ACTH-(1-24) dose 500 times lower (0.5 micrograms/1.73 m2) than the dose of 250 micrograms in the standard test. At 20 min, the peak cortisol level was the same in the low-dose test [(621 +/- 28 nmol/L) (22.5 +/- 1.0 microgram/dL)] as in the standard ACTH test [(654 +/- 31 nmol/L) (23.7 +/- 1.1 microgram/dL)]. Of 46 asthmatic patients who had been treated with inhaled beclomethasone dipropionate (482 +/- 42 micrograms/m2 daily; n = 32) or budesonide (507 +/- 62 micrograms/m2 daily; n = 14) for over 6 months, 16 (35%) failed to reach a cortisol peak of more than 500 nmol/L (18.1 micrograms/dL) following stimulation with 0.5 micrograms ACTH-(1-24)/1.73 m2. Of these, 11 (24%) showed a cortisol increment of less than 200 nmol/L (7.2 micrograms/dL). These 16 patients, showing insufficient response to low-dose ACTH-(1-24), also had a significantly lower (P < 0.01) mean 24-h urinary free cortisol excretion [(71 +/- 10 nmol/m2.24 h) (25.7 +/- 3.6 micrograms/m2.24 h)] than patients who responded normally [(118 +/- 11 nmol/m2.24 h) (42.8 +/- 4.0 micrograms/m2.24 h). Nonetheless, all but one of the poor responders to a 0.5 microgram ACTH showed normal stimulation with the standard 250 micrograms ACTH test. Therefore, it appears that a low-dose ACTH test is capable of revealing mild adrenal insufficiency, which is not detected by the standard high-dose ACTH test.

摘要

本研究的目的是探讨低剂量促肾上腺皮质激素(ACTH)-(1-24)刺激试验在评估肾上腺功能及检测轻度肾上腺皮质功能不全中的应用。ACTH-(1-24)正常反应的标准为皮质醇峰值水平超过500 nmol/L(18.1微克/分升),且皮质醇水平较基础值升高超过200 nmol/L(7.2微克/分升)。33名健康儿童和成人接受的ACTH-(1-24)剂量(0.5微克/1.73平方米)比标准试验中的250微克剂量低500倍,其中32人满足这些标准。在20分钟时,低剂量试验中的皮质醇峰值水平[(621±28 nmol/L)(22.5±1.0微克/分升)]与标准ACTH试验中的[(654±31 nmol/L)(23.7±1.1微克/分升)]相同。46名接受吸入丙酸倍氯米松(每日482±42微克/平方米;n = 32)或布地奈德(每日507±62微克/平方米;n = 14)治疗超过6个月的哮喘患者中,16人(35%)在接受0.5微克ACTH-(1-24)/1.73平方米刺激后未能达到皮质醇峰值超过500 nmol/L(18.1微克/分升)。其中,11人(24%)的皮质醇升高幅度小于200 nmol/L(7.2微克/分升)。这16名对低剂量ACTH-(1-24)反应不足的患者,其24小时尿游离皮质醇排泄均值[(71±10 nmol/平方米·24小时)(25.7±3.6微克/平方米·24小时)]也显著低于反应正常的患者[(118±11 nmol/平方米·24小时)(42.8±4.0微克/平方米·24小时)(P < 0.01)]。然而,除1人外,所有对0.5微克ACTH反应不佳的患者在标准的250微克ACTH试验中均显示正常刺激反应。因此,低剂量ACTH试验似乎能够揭示轻度肾上腺皮质功能不全,而标准的高剂量ACTH试验无法检测到这种情况。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验